Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
| 2 |
CVS Health
CVS
|
+$189M |
| 3 |
Mastercard
MA
|
+$155M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$112M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$814M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$763M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$315M |
| 4 |
SPDR Gold Trust
GLD
|
+$140M |
| 5 |
JD.com
JD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.96% |
| 2 | Healthcare | 19.03% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
VICI Properties
VICI
$29.4B
| $273K | ﹤0.01% |
+9,162
| New | +$270K |
|
952
Gaotu Techedu
GOTU
$436M
| $272K | ﹤0.01% |
138,848
-127,336
| -48% | -$204K |
|
953
Wendy's
WEN
$1.46B
| $271K | ﹤0.01% |
14,353
+2,243
| +19% | +$42.5K |
|
954
Teradata
TDC
$2.55B
| $268K | ﹤0.01% |
7,254
+1,291
| +22% | +$51.5K |
|
955
Pegasystems
PEGA
$5.38B
| $266K | ﹤0.01% |
+11,138
| New | +$333K |
|
|
BNR
956
Burning Rock Biotech
BNR
$92.9M
| $261K | ﹤0.01% |
8,969
-6,872
| -43% | -$307K |
|
957
Denali Therapeutics
DNLI
$3.94B
| $255K | ﹤0.01% |
8,660
+1,793
| +26% | +$47K |
|
|
PACW
958
DELISTED
PacWest Bancorp
PACW
| $251K | ﹤0.01% |
9,397
-3,461
| -27% | -$112K |
|
|
MRTX
959
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $249K | ﹤0.01% |
+3,714
| New | +$236K |
|
960
Natera
NTRA
$46.1B
| $248K | ﹤0.01% |
6,998
+1,620
| +30% | +$60K |
|
961
Madison Square Garden
MSGS
$9.39B
| $245K | ﹤0.01% |
+1,622
| New | +$263K |
|
962
Bank of Hawaii
BOH
$3.13B
| $239K | ﹤0.01% |
3,216
-1,062
| -25% | -$81.8K |
|
963
Peloton Interactive
PTON
$2.46B
| $239K | ﹤0.01% |
26,025
+7,522
| +41% | +$121K |
|
964
Mid-America Apartment Communities
MAA
$15.7B
| $234K | ﹤0.01% |
1,340
-8,590
| -87% | -$1.6M |
|
965
Sensient Technologies
SXT
$5.53B
| $228K | ﹤0.01% |
2,826
-161
| -5% | -$13.3K |
|
966
Royalty Pharma
RPRX
$25.2B
| $223K | ﹤0.01% |
5,309
-35,178
| -87% | -$1.44M |
|
967
Alnylam Pharmaceuticals
ALNY
$29.3B
| $221K | ﹤0.01% |
+1,512
| New | +$215K |
|
968
Nutanix
NTNX
$16.9B
| $221K | ﹤0.01% |
15,077
+3,286
| +28% | +$68.5K |
|
969
Upstart Holdings
UPST
$3.03B
| $218K | ﹤0.01% |
6,910
+2,634
| +62% | +$157K |
|
970
Associated Banc-Corp
ASB
$5.91B
| $214K | ﹤0.01% |
11,727
-4,406
| -27% | -$89.1K |
|
971
NewMarket
NEU
$8.18B
| $206K | ﹤0.01% |
+686
| New | +$222K |
|
|
SPR
972
DELISTED
Spirit AeroSystems
SPR
| $206K | ﹤0.01% |
7,034
+619
| +10% | +$22.2K |
|
973
Codexis
CDXS
$158M
| $205K | ﹤0.01% |
19,614
+564
| +3% | +$7.07K |
|
974
TripAdvisor
TRIP
$1.26B
| $180K | ﹤0.01% |
10,115
+1,666
| +20% | +$39.5K |
|
975
Aurora
AUR
$13.8B
| $160K | ﹤0.01% |
+83,607
| New | +$308K |
|
Similar funds
Ray Dalio's Q2 2022 Portfolio in Review
As of Q2 2022, Ray Dalio held 1,084 positions worth $23.6B, down 4.9% from $24.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ray Dalio deployed $1.38B of net new capital in Q2 2022, opening 116 new positions and adding to 613 existing holdings. Its largest new stake was Sea Limited: 459,240 shares worth $30.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $763M trimmed.
- Ray Dalio's largest Q2 2022 buy was Sea Limited: 459,240 shares worth $30.7M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $236M increase.
- Ray Dalio's biggest Q2 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $763M.
- Ray Dalio fully exited Alibaba in Q2 2022, selling an estimated $814M.
- Ray Dalio's ten largest holdings make up 29% of its $23.6B portfolio in Q2 2022.
- Ray Dalio opened 116 new positions and closed 99 in Q2 2022.
- Ray Dalio's portfolio value fell 4.9% quarter-over-quarter to $23.6B.
Based on Bridgewater Associates's 13F filing for Q2 2022, filed 11 Aug 2022.